Genzyme Technologies

From state-of-the-art technologies to innovative therapies

Genzyme's international team of over 400 scientists is continually working to identify new opportunities to meet the health care challenges of the future. Genzyme is committed to investing in their work, and in 2001, dedicated approximately $188 million - or 19 percent of total revenues - to internal research and development.

Building on over twenty years of leadership in biomedical research, Genzyme is leveraging the power of today's innovative technologies to refine its expertise in a broad range of scientific platforms. The company's areas of expertise include surgical biomaterials, cell and protein therapeutics, diagnostic products and services, small molecule/drug discovery, genetics and genomics and therapeutic polymers.

In addition to the research taking place in Genzyme's own laboratories, the company also supports vital research conducted by leading academic and independent medical science centers, and works collaboratively with its development partners to bring innovative therapies to market.

Across the organization, Genzyme is committed to creating, recognizing, and acting on scientific breakthroughs to develop the next generation of life-saving and life-enhancing medical products.

Privacy Policy - Canada USA | Terms and Conditions of Use | | © 2003-2012 Genzyme, a Sanofi company. All rights reserved.